Drugindustrydaily

View Archived Issues

Dec. 17, 2018

Vol. 17
No. 243

Headlines

Senators Introduce Bill to End ‘Predatory’ Pricing of Life-Saving Drugs

Four democratic senators introduced legislation aimed at ending “predatory” pricing of insulin and other life-saving drugs. The bill would give HHS authority to block any price increases on drugs that it deems “unjustified.” Read More

Kaléo Promises Generic Naloxone Injector After Blistering Senate Pricing Report

A month after a scathing congressional report hit Kaléo for hiking prices for its opioid antidote by 600 percent, the company announced it will release a lower-cost generic version of its auto-injector in 2019. Read More

CHMP Recommends Seven Drugs for Approval at December Meeting

The EMA’s Committee for Medicinal Products for Human Use recommended seven medicines at its Dec. 10-13 meeting for approval by the European Commission. Read More

Indian Drugmaker Warned After Refusing FDA Inspection

Indian drug manufacturer SkyLark CMC drew a warning letter from the FDA by denying the agency investigator access to its manufacturing facility in Ahmedabad, Gujarat. Read More